✦ LIBER ✦

Hypometabolism as a therapeutic target in Alzheimer's disease

✍ Scribed by Lauren C Costantini; Linda J Barr; Janet L Vogel; Samuel T Henderson

Book ID: 115007732
Publisher: BioMed Central
Year: 2008
Tongue: English
Weight: 331 KB
Volume: 9
Category: Article
ISSN: 1471-2202
DOI: 10.1186/1471-2202-9-s2-s16

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hypometabolism as a therapeutic target i

Hypometabolism as a therapeutic target in Alzheimer's disease

✍ Lauren C Costantini; Linda J Barr; Janet L Vogel; Samuel T Henderson 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 331 KB

The pathology of Alzheimer's disease (AD) is characterized by cerebral atrophy in frontal, temporal, and parietal regions, with senile plaques, dystrophic neurites, and neurofibrillar tangles within defined areas of the brain. Another characteristic of AD is regional hypometabolism in the brain. Thi

NADPH oxidase as a therapeutic target in

NADPH oxidase as a therapeutic target in Alzheimer's disease

✍ Michelle L Block 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 480 KB

β-Secretase as a therapeutic target for

β-Secretase as a therapeutic target for Alzheimer’s disease

✍ Arun K. Ghosh; Sandra Gemma; Jordan Tang 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 339 KB

Apolipoprotein E as a therapeutic target

Apolipoprotein E as a therapeutic target for Alzheimer's disease

✍ Robert W. Mahley 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Secretases as therapeutic targets for Al

Secretases as therapeutic targets for Alzheimer’s disease

✍ Ha-Na Woo; Sang-Ha Baik; Jong-Sung Park; A-Ryeong Gwon; Sunghee Yang; Young-Kwan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 297 KB

Phosphodiesterases as Therapeutic Target

Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease

✍ García-Osta, Ana; Cuadrado-Tejedor, Mar; García-Barroso, Carolina; Oyarzábal, Ju 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 755 KB